MDMA Annual Meeting
The 2012 MDMA Annual Meeting will provide the definitive opportunity to learn how the United States can remain the global leader in med-tech innovation, and how we can all play a role in shaping the regulatory and legislative agendas. This must-attend event will be a powerful opportunity to build relationships while networking with more than 200 med-tech CEOs and senior executives. Register now.
C21 BioVentures 2012 - Defining The New Reality
C21 BioVentures™ (C21), annually held in Napa Valley California at the Meritage Resort May 22-24, 2012, is an intimate venue designed for small enterprises to showcase innovation and to network with potential partners for funding sources. In today’s economic climate, life science companies have found they must make changes or continued existence will be difficult. The 14th Annual C21 BioVentures™ conference will explore how various biopharma companies have found ways to thrive and prosper. Join in lively discussions and arrange face to face meetings with pharma scouts that are seeking licensing deals for their next R&D facility. Check out our program online. Email rlindsey@techvision.com or call +1.831.464.4230
Clinical Trials Eastern Europe Webinar Series
Webinar series hosted by regional experts addressing the opportunities and risks of running clinical trials in Central and Eastern Europe. Series topics will include an introduction to the region and specific discussions on pulmonology, oncology, and endovascular studies. Register now.
BioImmersion Course
This three-day course delivers an in-depth understanding of both fundamental and advanced biotechnology concepts used in both biotech and pharma companies. Register now.
Association Bioscience Financial Officers 2012 Conference
Senior Bioscience Financial Officers: network, earn CPE, hear from expert speakers Ian F. Smith, Henri A. Termeer, Robert S. Langer, Jr., Gary P. Pisano and more on “Innovation:Breakthroughs in Science and Business” at the 2012 ABFO Conference in Boston. For information and to register, click HERE.
Don't miss an Exclusive Executive Breakfast at BIO 2012!
Join FierceBiotech Editor-in-Chief John Carroll on Tuesday, June 19 in Boston, as he sits down with executives from GlaxoSmithKline, AstraZeneca, Sanofi, Catabasis Pharmaceuticals, and InnoThink Center to review the fast-changing ecosystem for drug R&D. Early Bird Pricing Ends 6/1: Register Today!
Latest Commentary